Erratum to "Recombinant human relaxin reduces hypoxic pulmonary hypertension in the rat" [Pulmonary Pharmacology & Therapeutics 18 (2005) 346-353] (DOI:10.1016/j.pupt.2005.01.003);Recombinant human relaxin reduces hypoxic pulmonary hypertension in the rat

Pulmonary Pharmacology and Therapeutics

Volumn 18, Issue 5, 2005, Pages 346-353

  Tozzi, Carol A ^a,d   Poiani, George J ^a,e   McHugh, Nansie A ^a,d   Sharkarjian, Michael P ^a   Grove, Beverly H ^b   Samuel, Chrishan S ^c   Unemori, Elaine N ^b   Riley, David J ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b Bradley Pharmaceuticals Inc   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MERCK RESEARCH LABORATORIES   (United States)

^e Schering Plough Research Institute ^*  (United States)

Author keywords

Collagen; Fibrogenesis; Hypertension; Pulmonary; Relaxin; Vascular remodeling

Indexed keywords

COLLAGEN; FIBRONECTIN; HYDROXYPROLINE; RECOMBINANT RELAXIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BREATHING; COLLAGEN SYNTHESIS; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; FIBROBLAST CULTURE; HEART RIGHT VENTRICLE PRESSURE; HYPOXIA; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT;

EID: 20444403035     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2005.09.001     Document Type: Erratum

References (42)

1. D.J. Riley, S. Thakker-Varia, G.J. Poiani, and C.A. Tozzi Vascular remodeling R.G. Crystal P.J. Barnes J.B. West E.R. Weibel The Lung. Scientific Foundations 2nd ed. 1997 1589 1598
2. G.J. Poiani, D.J. Riley, J.K. Choi, S.E. Yohn, and D.J. Riley An antifibrotic agent reduces blood pressure in established pulmonary hypertension J Appl Physiol 68 1990 1542 1547
3. J.S. Kerr, D.J. Riley, M.M. Frank, R.L. Trelstad, and H.M. Frankel Reduction of chronic hypoxic pulmonary hypertension in the rat by beta-aminopropionitrile J Appl Physiol 57 1984 1760 1766
4. J.S. Kerr, C.L. Ruppert, C.A. Tozzi, J.A. Neubauer, H.M. Frankel, and S.Y. Yu Reduction of chronic hypoxic pulmonary hypertension in the rat by an inhibitor of collagen production Am Rev Respir Dis 135 1987 300 306
5. C.A. Tozzi, D.L. Christiansen, G.J. Poiani, and D.J. Riley Excess collagen in hypertensive pulmonary arteries decreases vascular distensibility Am J Respir Crit Care Med 149 1994 1316 1326
6. D.J. Prockop, and K.I. Kivrikko COLLAGENS: molecular biology, diseases, and potentials for therapy Annu Rev Biochem 64 1995 403 434
7. H.J. Chihal, and L.L. Espey Utilization of the relaxed symphysis pubis of guinea pigs for clues to the mechanism of ovulation Endocrinology 93 1973 1441 1445
8. E.N. Unemori, and E.P. Amento Relaxin modulates synthesis and secretion of procollagens and collagen by human dermal fibroblasts J Biol Chem 265 1990 10681 10685
9. E.N. Unemori, L.B. Pickford, A.L. Salles, C.E. Piercy, B.H. Grove, and M.E. Erikson Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo J Clin Invest 98 1996 2739 2745
10. G.A. McDonald, P. Sarkar, H. Rennke, E. Unemori, R. Kalluri, and V.P. Sukhatme Relaxin increases ubiquitin-dependent degradation of fibronectin in vitro and ameliorates renal fibrosis in vivo Am J Physiol 285 2003 F59 F67 10.1152/ajprenal.00157.02002
11. E.N. Unemori, L.S. Beck, W.P. Lee, Y. Xu, M. Siegel, and G. Keller Human relaxin decreases collagen accumulation in vivo in two rodent models of fibrosis J Invest Dermatol 101 1993 280 285
12. N.J. Kenyon, R.W. Ward, and J.A. Last Airway fibrosis in a mouse model of airway inflammation Tox Appl Pharmacol 186 2003 90 100 110.1016/S0041- 1008X(1002)00025-X
13. S.L. Garber, Y. Mirochnik, C.S. Brecklin, E.N. Unemori, A.K. Singh, and L. Slobodskoy Relaxin decreases renal interstitial fibrosis and slows progression of renal disease Kidney Int 59 2001 876 882
14. S.L. Garber, Y. Mirochnik, C. Brecklin, L. Solbodskoy, J.A. Arruda, and G. Dunea Effect of elastin in two models of renal mass reduction Am J Nephrol 23 2003 8 12
15. X.-J. Du, C.S. Samuel, X-M. Goa, L. Zhao, L.J. Parry, and G.W. Tregear Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype Cardiovasc Res 57 2003 395 404
16. C.S. Samuel, C. Zhao, R.A. Bathgate, C.P. Bond, M.D. Burton, and L.J. Parry Relaxin deficiency in mice is associated with an age-related progression of pulmonary fibrosis FASEB J 17 2003 121 123 110.1096/fj.1002.0449fje
17. L.A. Danielson, O.D. Sherwood, and K.P. Conrad Relaxin is a potent renal vasodilator in conscious rats J Clin Invest 103 1999 525 533
18. L.A. Danielson, and K.P. Conrad Time course and dose response of relaxin-mediated vasodilation, hyperfiltration, and changes in plasma osmolality in conscious rats J Appl Physiol 95 2003 1509 1514 1510.1152/japplphysiol. 00545.02003
19. T. Dschietzig, C. Bartsch, C. Richter, M. Laule, G. Baumann, and K. Stangl Relaxin, a pregnancy hormone, is a functional endothelin-1 antagonist: attenuation of endothelin-1-mediated vasoconstriction by stimulation of endothelin type-B receptor expression via ERK-1/2 and nuclear factor-kB Circ Res 92 2003 32 40 10.1161/1101.RES.0000051884.0000027117.0000051887E
20. C. Fisher, M. MacLean, I. Morecroft, A. Seed, F. Johnson, and C. Hillier Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart? Circulation 106 2002 292 295 210.1161/1101.CIR.0000025630.0000005387. 0000025645
21. G. Massicotte, A. Parent, and J. St-Louis Blunted responses to vasoconstrictors in mesenteric vasculature but not in portal vein of spontaneously hypertensive rats treated with relaxin (42857) Proc Soc Exp Biol Med 190 1989 254 259
22. T. Bani-Sacchi, M. Bigazzi, D. Bani, P.F. Mannaioni, and E. Masini Relaxin-induced increased coronary flow through stimulation of nitric oxide production Br J Pharmacol 116 1995 1589 1594
23. T. Hasuda, T. Satoh, A. Shimouchi, S. Kyotani, T. Matsumoto, and Y. Goto Improvement in exercise capacity with nitric oxide inhalation in patients with precapillary pulmonary hypertension Circulation 101 2000 2066 2070
24. B. Weinberger, D.E. Heck, D.L. Laskin, and J.D. Laskin Nitric oxide in the lung: therapeutic and cellular mechanisms of action Pharmacol Ther 84 1999 401 411
25. K.P. Conrad, D.O. Debrah, J. Novak, L.A. Danielson, and S.G. Shroff Relaxin modifies systemic arterial resistance and compliance in conscious, nonpregnant rats Endocrinology 145 2004 3289 3296 3210.1210/en.2003.1612
26. M. Das, E.C. Dempsey, D. Bouchey, M.E. Reyland, and K.R. Stenmark Chronic hypoxia induces exaggerated growth responses in pulmonary artery adventitial fibroblasts: potential contribution of specific protein kinase C isozymes Am J Respir Cell Mol Biol 22 2000 15 25
27. P.J. Sime, and K.M.A. O'Reilly Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment Clin Immunol 99 2001 308 319 310.1006/clim.2001.5008
28. J. Widimiský, D. Urbanová, J. Ressl, B. Oštadal, V. Pelouch, and J. Procházka Effect of intermittent altitude hypoxia on the myocardium and lesser circulation in the rat Cardiovasc Res 7 1973 798 808
29. L.M. Reid Structure and function in pulmonary hypertension. New perceptions Chest 89 1986 279 288
30. G.J. Poiani, C.A. Tozzi, S.E. Yohn, R.A. Pierce, S.A. Belsky, and R.A. Berg Collagen and elastin metabolism in hypertensive pulmonary arteries of rats Circ Res 66 1990 968 978
31. K.I. Kivirikko, O. Laitinen, and D.J. Prockop Modifications of a specific assay for hydroxyproline in urine Anal Chem 19 1967 249 255
32. S. Moore, and W.H. Stein Photometric ninhydrin method for use in the chromatography of amino acids J Biol Chem 176 1948 367 388
33. SAS/STAT User's Guide. Version 6. Cary, NC: SAS Institute.
34. O.D. Sherwood, V.E. Crnekovic, W.L. Gordon, and J.E. Rutherford Radioimmunoassay of relaxin throughout pregnancy and during parturition in the rat Endocrinology 107 1980 691 698
35. L. Biljanovic-Paunovic, G.K. Clemons, Z. Ivanovic, and V. Pavlovic-Kentera Erythropoietin & erythroid progenitors in rats exposed to chronic hypoxia Indian J Med Res 104 1996 304 310
36. L.A. Danielson, L.J. Kercher, and K.P. Conrad Impact of gender and endothelin on renal vasodilation and hyperfiltration induced by relaxin in conscious rats Am J Physiol 279 2000 R1298 R1304
37. D.D. Ivy, J.P. Kinsella, and S.H. Abman Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary artery circulation J Clin Invest 93 1994 2141 2148
38. E.L. Schriffrin Endothelin and endothelin antagonists in hypertension J Hypertens 16 1998 1891 1895
39. R.I. Cargill, and B.J. Lipworth The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature Br J Clin Pharmacol 40 1995 11 18
40. M. Toth, P. Taskinen, and H. Ruskoaho Relaxin stimulates atrial natriuretic peptide secretion in perfused rat heart J Endocrinol 150 1996 487 495
41. J. Novak, R.J.J. Ramirez, R.E. Gandley, O.D. Sherwood, and K.P. Conrad Myogenic reactivity is reduced is small renal arteries isolated from relaxin-treated rats Am J Physiol 283 2002 R349 R355 310.1152/ajpregu.00635. 02001
42. P.C. Russell, C.E. Wright, G.R. Barer, and P. Howard Histamine induced pulmonary vasodilation in the rat: site of action and changes in chronic hypoxia Eur Respir J 7 1994 1138 1144